SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Sanofi Consumer Healthcare India Ltd

BSE: 544250 NSE: SANOFICONR ISIN: INE0UOS01011
  |   Sector:  Healthcare   |   Industry:  Pharmaceuticals & Drugs

Snapshot

Q.1 Which industry/sub-sector does Sanofi Consumer Healthcare India Ltd belong to?
Sanofi Consumer Healthcare India Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.
Q.2 Is Sanofi Consumer Healthcare India Ltd a good quality company?
Sanofi Consumer Healthcare India Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

Q.3 Is Sanofi Consumer Healthcare India Ltd undervalued or overvalued?
Sanofi Consumer Healthcare India Ltd appears Undervalued, as its key valuation ratios are lower than their past averages.

Based on the industry it operates in, the relevant valuation ratios include one of the following, P/E, P/BV, P/Sales, EV/EBITDA or a combination of two or more.

Valuation Ratios Current 0-year
Historic Median
Price to Earnings 42.06 -
Price to Book 24.01 5.32
Price to Sales 11.6 10.28
EV to EBITDA 29.7 54.77
Q.4 Is Sanofi Consumer Healthcare India Ltd a good buy now?
Sanofi Consumer Healthcare India Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

C: How much debt does the business have and is it at a sustainable level?

Q.1 Debt to Equity ratio of Sanofi Consumer Healthcare India Ltd?
Sanofi Consumer Healthcare India Ltd Debt-to-Equity ratio is 0.00, which is in line with the industry average of , indicating similar to debt levels in the industry.

Q.2 Debt to cash flow from operations of Sanofi Consumer Healthcare India Ltd?
Sanofi Consumer Healthcare India Ltd Debt to cash flow from operations is 0, which is at a healthy level.

Ownership & governance

D: Promoter shareholding and pledge status of Sanofi Consumer Healthcare India Ltd?

Q.1 Promoter shareholding and pledge status of Sanofi Consumer Healthcare India Ltd?
Promoters hold 71.27% of the Sanofi Consumer Healthcare India Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

E: How does Sanofi Consumer Healthcare India Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Sanofi Consumer Healthcare India Ltd vs industry peers?
Sanofi Consumer Healthcare India Ltd revenue CAGR is %, compared to the industry median CAGR of 4.57%, indicating slower growth and losing its market share.
Profit Metrics
Current Level 0-year
Industry Median
Revenue Growth (%) - 4.6
Gross Profit Growth (%) 25.6 21.7
Operating Profit Growth (%) 23.7 18.6
Net Profit Growth (%) 9.7 28.5
Operating Efficiency
Current Level 0-year
Industry Median
Asset Turnover (x) 1.7 1.18
ROE (%) - 9.33
ROCE (%) - 13.25
Cash Conversion Cycle (days) -18.23 90

Valuation & price assessment

Q.1 Stock return of Sanofi Consumer Healthcare India Ltd over the last decade?
Over the last 1 year(s), the stock has delivered a CAGR of -6.21% based on the current price.
9Y 5Y 3Y 1Y
Share Price
CAGR		 - - - -6.2%
Q.2 Valuation ratios of Sanofi Consumer Healthcare India Ltd vs historical?
The current P/E ratio of 42.06 is higher than its historical median of , indicating that the stock is trading above its historical average valuation.
Q.3 How do the current valuation ratios compare with 0-year historical median and industry numbers?
Valuation Ratios Current 0-year
Historic Median		 0-year
Industry Median
Price to Earnings 42.06 - -
Price to Book 24.01 5.32 -
Price to Sales 11.6 10.28 -
EV to EBITDA 29.7 54.77 -

Check more companies

1. Gland Pharma
2. JB Chem & Pharma
3. Emcure Pharma
4. Wockhardt
5. Acutaas Chemicals
6. Sai Life Sciences
7. Piramal Pharma
8. Astrazeneca Pharma I
9. Neuland Laboratories
10. Onesource Specialty

Check trending companies

1. Granules India Ltd.
2. Nestle India Ltd.
3. National Aluminium Company Ltd.
4. Muthoot Finance Ltd.
5. Motilal Oswal Financial Services Ltd.
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×